Are you struggling with depression that hasn’t responded to traditional antidepressants? At Ketavita Wellness Clinic in Wyckoff, NJ, we understand how debilitating major depressive disorder can be. While conventional treatments help many patients, research from the National Institute of Mental Health shows that approximately 30% of depression cases are treatment-resistant, leaving millions searching for alternatives.
That’s why we specialize in innovative, evidence-based therapies that offer hope when standard approaches fall short. Our clinic provides four advanced depression treatment modalities: IV Ketamine Infusion Therapy, IM Ketamine Injections, SPRAVATO® (esketamine) nasal spray, and Transcranial Magnetic Stimulation (TMS). These breakthrough treatments have demonstrated rapid symptom relief—often within hours to days rather than weeks—according to clinical studies published in the American Journal of Psychiatry.
IV Ketamine Therapy provides rapid-acting relief through intravenous infusion. Ketamine works through the glutamate system rather than traditional serotonin pathways, promoting neuroplasticity and helping reset disrupted brain patterns associated with depression. Many patients experience improvement within hours to days rather than the weeks typically required for conventional antidepressants.
IV Ketamine Therapy provides rapid-acting relief through intravenous infusion. Ketamine works through the glutamate system rather than traditional serotonin pathways, promoting neuroplasticity and helping reset disrupted brain patterns associated with depression. Many patients experience improvement within hours to days rather than the weeks typically required for conventional antidepressants.
SPRAVATO® (Esketamine Nasal Spray) is the first and only FDA-approved medication specifically for treatment-resistant depression. As an NMDA receptor antagonist that works through the glutamate system, SPRAVATO® provides rapid symptom improvement and may be covered by insurance for eligible patients who meet FDA criteria for treatment-resistant depression
Research from Yale University demonstrates that ketamine rapidly increases brain-derived neurotrophic factor (BDNF), promoting new neural connections and potentially reversing the brain changes caused by chronic depression. This mechanism explains why patients often experience relief when other treatments have failed.
TMS Therapy uses focused magnetic fields to stimulate nerve cells in specific brain regions involved in mood regulation. This non-invasive, FDA-approved treatment for treatment-resistant depression doesn’t require anesthesia and allows you to resume normal activities immediately after sessions. TMS may also be covered by insurance when medical necessity criteria are met.
Each treatment works through unique mechanisms, and the right option depends on your individual situation, treatment history, insurance coverage, and personal preferences. We’ll help you understand which approach may be most appropriate for your needs.
Your depression treatment journey at Ketavita begins with a comprehensive evaluation. We’ll discuss your depression history, including when symptoms began, previous treatments you’ve tried and their results, current symptoms and their severity, and how depression affects your daily functioning. This thorough assessment helps us determine which treatment option is most appropriate for your situation.
If you’re a candidate for treatment, we’ll develop a personalized care plan that includes the specific treatment protocol, expected timeline and treatment frequency, what to expect during sessions, and monitoring procedures to track your progress. We ensure you understand every aspect of your treatment before beginning.
For ketamine therapy, your first session typically lasts longer than follow-up visits to allow adequate time for preparation, treatment, and recovery. You’ll receive your infusion or injection in a comfortable setting with medical monitoring throughout. After treatment, you’ll spend time recovering in our office before leaving with your designated driver.
For SPRAVATO®, you’ll self-administer the nasal spray under our direct medical supervision, then remain in our office for at least two hours of observation. Treatment begins with an induction phase of twice-weekly sessions, followed by less frequent maintenance dosing based on your response.
For TMS therapy, sessions last 20-40 minutes and don’t require sedation or recovery time. You’ll receive daily treatments five days per week for 4-6 weeks. The magnetic pulses create a tapping sensation on your scalp, but the procedure is generally well-tolerated.
Response varies among individuals. Some people notice improvements quickly, while others require several sessions before experiencing benefits. We monitor your progress closely through regular check-ins, using standardized assessment tools to track symptom changes and making adjustments to optimize your treatment response.
Our specialized depression treatments may be appropriate if you’ve struggled with persistent depression despite trying conventional approaches. You may be a candidate if you’ve tried at least two different antidepressant medications without adequate relief, experienced intolerable side effects from antidepressants that prevented you from continuing treatment, or found that initial improvements from treatment faded over time leaving you with ongoing symptoms.
Good candidates for treatment are adults with diagnosed major depressive disorder who remain symptomatic despite appropriate treatment attempts. For SPRAVATO® specifically, FDA approval requires documented treatment-resistant depression with inadequate response to at least two different antidepressants.
Certain medical conditions or medications may affect treatment candidacy. During your evaluation, we review your complete medical history to ensure safety and appropriateness. Factors we consider include current medications and potential interactions, cardiovascular health (particularly for ketamine treatments), history of substance use disorders, and any conditions that might contraindicate specific treatments.
The best way to determine if our depression treatments are right for you is through a personal consultation. We’ll assess your individual situation, discuss the potential benefits and considerations of each treatment option, and help you make an informed decision about the approach most likely to help you achieve meaningful improvement.
We stay current with the latest research in depression treatment and follow evidence-based protocols proven effective in clinical studies. Our treatments are FDA-approved or extensively researched for depression, and we continuously refine our approaches based on emerging science and clinical outcomes.
Safety is our highest priority. All treatments are administered by licensed medical professionals in a controlled clinical setting with appropriate monitoring and emergency protocols. We conduct thorough health screenings before treatment, monitor you closely during sessions, and provide clear aftercare instructions to ensure your wellbeing throughout the treatment process.
We understand that effective depression care often requires a comprehensive approach. While our specialized treatments can provide significant symptom relief, we encourage patients to maintain other aspects of their mental health care, including psychotherapy, appropriate medications, lifestyle modifications, and support systems. We coordinate with your other healthcare providers when appropriate to ensure cohesive, integrated care.
Patient education is central to our approach. We ensure you understand your treatment options, know what to expect, and feel empowered to participate actively in treatment decisions. We’re always available to answer questions and address concerns throughout your journey with us.
Insurance coverage varies significantly depending on the specific treatment and your insurance plan. SPRAVATO® and TMS therapy may be covered by many insurance plans when medical necessity criteria are met, particularly for treatment-resistant depression. We recommend contacting your insurance provider to verify coverage and understand your out-of-pocket costs.
IV and IM ketamine therapy are typically not covered by insurance as they represent off-label use for depression. We provide transparent pricing information during your consultation: IV ketamine for depression is $395 per session, and we can discuss treatment packages and session requirements based on your needs.
We view depression treatment as an important investment in your health and quality of life. While cost is a consideration, we believe access to effective treatment shouldn’t be limited by financial barriers. We’re happy to discuss payment options and work with you to make treatment as accessible as possible.
For treatments that may be covered by insurance, we can provide the necessary documentation to support your claim. Even for non-covered treatments, we can supply receipts and documentation that you may submit for possible out-of-network reimbursement.
If you’ve been struggling with depression despite trying traditional treatments, specialized care at Ketavita Wellness Clinic may offer the breakthrough you’ve been seeking. Our evidence-based approaches provide new hope for managing treatment-resistant depression through mechanisms that work differently than conventional antidepressants.
Taking the first step toward better mental health starts with a conversation. We invite you to schedule a consultation where we’ll discuss your depression history, explore treatment options, and determine the best path forward for your individual situation.
Van Bronswijk SC, Moopen N, Beijers L, et al. A systematic review and network meta-analysis of psychological, psychosocial, pharmacological, physical and combined treatments for adults with a new episode of depression. eClinicalMedicine. 2024;75:102780. https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00359-6/fulltext
Cepeda MS, Williamson T, Kern DM, Defalco F. Relative effectiveness of antidepressant treatments in treatment-resistant depression: a systematic review and network meta-analysis of randomized controlled trials. Neuropsychopharmacology. 2024. https://www.nature.com/articles/s41386-024-02044-5
Mental Health Conditions
Conditions Treated
365 Franklin Avenue, Wyckoff, NJ 07481